The Swiss stock market finished lower on Wednesday, retracing the rebound seen during the previous session.
The Greek government survived a confidence vote in the country's parliament, allowing officials to concentrate on implementing the austerity proposals necessary to keep Greece's debt bailout in place. However, this news was already priced into the market and did little to boost stocks.
Meanwhile, caution dominated trading throughout the session, ahead of the regular interest-rate announcement from the U.S. Federal Reserve.
The benchmark SMI dropped 0.93 percent on the day to close at 6,113.44. The SLI slipped 0.6 percent to 951.16. The SPI declined by 0.72 percent to 5,623.13.
In corporate news, Novartis finished the session lower by 1.0 percent. An advisory panel at the U.S. Food And Drug Administration voted against recommending the company's gout drug. This was counteracted by news that Merck KGaA was going to stop developing a multiple-sclerosis drug, a boost for Novartis' Gilenya medicine.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.